Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert Kuhl

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Maturitas|May 11, 2005
Breast cancer risk in the WHI study: the problem of obesityHerbert Kuhl
Maturitas|April 6, 2004
Mechanisms of sex steroids. Future developmentsHerbert Kuhl
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 21, 2006
The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative resultsHerbert Kuhl, John Stevenson
Drugs|October 16, 2004
Long-cycle treatment with oral contraceptivesInka Wiegratz, Herbert Kuhl
Treatments in Endocrinology|April 19, 2005
Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptivesInka Wiegratz, Herbert Kuhl
Trends in Endocrinology and Metabolism: TEM|September 11, 2004
Progestogen therapies: differences in clinical effects?Inka Wiegratz, Herbert Kuhl
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 24, 2006
Metabolic and clinical effects of progestogensInka Wiegratz, Herbert Kuhl
Menopause (New York, N.Y.)|June 26, 2002
Formation of 7 alpha-methyl-ethinyl estradiol during treatment with tiboloneInka Wiegratz, Nicole Sänger, Herbert Kuhl
Women'S Health (London, England)|October 7, 2009
Extended and continuous use of hormonal contraceptives to reduce menstruationInka Wiegratz, Stefan Kissler, Herbert Kuhl, et al.
Biochemical Pharmacology|July 11, 2002
Modulation of tamoxifen-induced apoptosis by peripheral benzodiazepine receptor ligands in breast cancer cellsRenate Strohmeier, Marc Roller, Nicole Sänger, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Maturitas|May 11, 2005
Breast cancer risk in the WHI study: the problem of obesityHerbert Kuhl
Maturitas|April 6, 2004
Mechanisms of sex steroids. Future developmentsHerbert Kuhl
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 21, 2006
The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative resultsHerbert Kuhl, John Stevenson
Drugs|October 16, 2004
Long-cycle treatment with oral contraceptivesInka Wiegratz, Herbert Kuhl
Treatments in Endocrinology|April 19, 2005
Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptivesInka Wiegratz, Herbert Kuhl
Trends in Endocrinology and Metabolism: TEM|September 11, 2004
Progestogen therapies: differences in clinical effects?Inka Wiegratz, Herbert Kuhl
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 24, 2006
Metabolic and clinical effects of progestogensInka Wiegratz, Herbert Kuhl
Menopause (New York, N.Y.)|June 26, 2002
Formation of 7 alpha-methyl-ethinyl estradiol during treatment with tiboloneInka Wiegratz, Nicole Sänger, Herbert Kuhl
Women'S Health (London, England)|October 7, 2009
Extended and continuous use of hormonal contraceptives to reduce menstruationInka Wiegratz, Stefan Kissler, Herbert Kuhl, et al.
Biochemical Pharmacology|July 11, 2002
Modulation of tamoxifen-induced apoptosis by peripheral benzodiazepine receptor ligands in breast cancer cellsRenate Strohmeier, Marc Roller, Nicole Sänger, et al.
Pageof 3